Skip to main content

Advertisement

Log in

CC chemokine receptor 5 polymorphism in Italian patients with giant cell arteritis

  • Original Article
  • Published:
Modern Rheumatology

Abstracts

Objectives

To evaluate the potential role of CC chemokine receptor 5 (CCR5)Δ32 polymorphism in the susceptibility to giant cell arteritis (GCA) in a cohort of Italian patients.

Methods

176 consecutive Italian patients with biopsy-proven GCA and 180 healthy age- and sex-matched blood donors were molecularly genotyped for the CCR5Δ32 polymorphism.

Results

No statistically significant difference in the Δ32CCR5 allele frequency between GCA patients (5.1 %) and controls (2.8 %) was observed (p = 0.109). Carriers of the CCR5Δ32 allele (Δ32/Δ32 + CCR5/Δ32) were similarly represented in the two groups.

Conclusions

Our results do not support a role for the CCR5Δ32 polymorphism in determining susceptibility to GCA.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Gonzalez-Gay MA, Vazquez-Rodriguez TR, Lopez-Diaz MJ, Miranda-Filloy JA, Gonzalez-Juanatey C, Martin J, et al. Epidemiology of giant cell arteritis and polymialgia rheumatica. Arthritis Rheum. 2009;61:1454–61.

    Article  PubMed  Google Scholar 

  2. Gonzalez-Gay MA, Amoli MM, Garcia-Porrua C, Ollier WR. Genetic markers of disease susceptibility and severity in giant cell arteritis and polymyalgia rheumatica. Semin Arthritis Rheum. 2003;33:38–48.

    Article  PubMed  CAS  Google Scholar 

  3. Weyand CM, Hicok KC, Hunder GG, Goronzy J. The HLA-DRB1 locus as a genetic component in giant cell arteritis. Mapping of a disease-linked sequence motif to the antigen binding site of the HLA-DR molecule. J Clin Invest. 1992;90:2355–61.

    Article  PubMed  CAS  Google Scholar 

  4. Boiardi L, Casali B, Farnetti E, Pipitone N, Nicoli D, Macchioni P, et al. Interleukin-10 promoter polymorphisms in giant cell arteritis. Arthritis Rheum. 2006;54:4011–7.

    Article  PubMed  CAS  Google Scholar 

  5. Salvarani C, Casali B, Nicoli D, Farnetti E, Macchioni P, Catanoso MG, et al. Endothelial nitric oxide synthase gene polymorphisms in giant cell arteritis. Arthritis Rheum. 2003;48:3219–23.

    Article  PubMed  CAS  Google Scholar 

  6. Ward SG, Marelli-Berg FM. Mechanisms of chemokine and antigen-dependent T-lymphocyte navigation. Biochem J. 2009;418:13–27.

    Article  PubMed  CAS  Google Scholar 

  7. Charo IF, Ransohoff RM. The many roles of chemokines and chemokine receptors in inflammation. N Engl J Med. 2006;354:610–21.

    Article  PubMed  CAS  Google Scholar 

  8. Mueller A, Strange PG. The chemokine receptor, CCR5. Int J Biochem Cell Biol. 2004;36:35–8.

    Article  PubMed  CAS  Google Scholar 

  9. Brühl H, Vielhauer V, Weiss M, Mack M, Schlöndorff D, Segerer S. Expression of DARC, CXCR3 and CCR5 in giant cell arteritis. Rheumatology. 2005;44:309–13.

    Article  PubMed  Google Scholar 

  10. O’Brien SJ, Moore JP. The effect of genetic variation in chemokines and their receptors on HIV transmission and progression to AIDS. Immunol Rev. 2000;177:99–111.

    Article  PubMed  Google Scholar 

  11. Martens HA, Kallenberg CG, Bijl M. Role of CCR5 delta32 bp deletion in RA and SLE. Autoimmunity. 2009;42:260–2.

    Google Scholar 

  12. Petrek M, Gibejova A, Drabek J, Mrazek F, Kolek V, Weigl E, et al. CC chemokine receptor 5 (CCR5) mRNA expression in pulmonary sarcoidosis. Immunol Lett. 2002;80(189):93.

    Google Scholar 

  13. Kantor R, Bakhanashvili M, Achiron A. A mutated CCR5 gene may have favorable prognostic implications in MS. Neurology. 2003;61(238):40.

    Google Scholar 

  14. Carmona FD, Rodríguez-Rodríguez L, Castañeda S, Miranda-Filloy JA, Morado IC, Narváez J, et al. Role of the CCR5/Δ32CCR5 polymorphism in biopsy-proven giant cell arteritis. Hum Immunol. 2011;72:458–61.

    Article  PubMed  CAS  Google Scholar 

  15. Gonzalez-Gay MA, Garcia-Porrua C, Llorca J, Gonzalez-Louzao C, Rodriguez-Ledo P. Biopsy-negative giant cell arteritis: clinical spectrum and predictive factors for positive temporal artery biopsy. Semin Arthritis Rheum. 2001;30:249–56.

    Article  PubMed  CAS  Google Scholar 

  16. Restuccia G, Cavazza A, Boiardi L, Pipitone N, Macchioni P, Bajocchi G, et al. Small-vessel vasculitis surrounding an uninflamed temporal artery and isolated vasa vasorum vasculitis of the temporal artery: two subsets of giant cell arteritis. Arthritis Rheum. 2012;64:549–56.

    Article  PubMed  Google Scholar 

  17. Yang B, Houlberg K, Millward A, Demaine A. Polymorphisms of chemokine and chemokine receptors in type 1 diabetes mellitus and its complications. Cytokine. 2004;26:114–21.

    Article  PubMed  CAS  Google Scholar 

  18. Odum N, Bregenholt S, Eriksen KW, Skov S, Ryder LP, Bendtzen K, et al. The CC-chemokine receptor 5 (CCR5) is a marker of, but not essential for the development of human Th1 cells. Tissue Antigens. 1999;54:572–7.

    Article  PubMed  CAS  Google Scholar 

  19. Berce V, Repnik K, Potocnik U. Association of CCR5-delta32 mutation with reduced risk of nonatopic asthma in Slovenian children. J Asthma. 2008;45:780–4.

    Article  PubMed  CAS  Google Scholar 

  20. Petrek M, Cermáková Z, Hutyrová B, Miceková D, Drábek J, Rovensky J, et al. CC chemokine receptor 5 and interleukin-1 receptor antagonist gene polymorphisms in patients with primary Sjögren’s syndrome. Clin Exp Rheumatol. 2002;20:701–3.

    PubMed  CAS  Google Scholar 

  21. Pokorny V, McQueen F, Yeoman S, Merriman M, Merriman A, Harrison A, et al. Evidence for negative association of the chemokine receptor CCR5 d32 polymorphism with rheumatoid arthritis. Ann Rheum Dis. 2005;64:487–90.

    Article  PubMed  CAS  Google Scholar 

  22. Zhou Y, Huang D, Farver C, Hoffman GS. Relative importance of CCR5 and antineutrophil cytoplasmic antibodies in patients with Wegener’s granulomatosis. J Rheumatol. 2003;30:1541–7.

    PubMed  CAS  Google Scholar 

  23. Petrek M, Drábek J, Kolek V, Zlámal J, Welsh KI, Bunce M, et al. CC chemokine receptor gene polymorphisms in Czech patients with pulmonary sarcoidosis. Am J Respir Crit Care Med. 2000;162:1000–3.

    Article  PubMed  CAS  Google Scholar 

  24. Atzeni F, Boiardi L, Casali B, Farnetti E, Sarzi-Puttini PC, Pipitone N et al. CC Chemokine receptor 5 polymorphism in italian patients with Behçet’s disease. Rhematology 2012 (in press).

  25. Boiardi L, Vaglio A, Nicoli D, Farnetti E, Palmisano A, Pipitone N, et al. CC chemokine receptor 5 polymorphism in chronic periaortitis. Rheumatology. 2011;50:1025–32.

    Article  PubMed  CAS  Google Scholar 

  26. Ghilardi G, Biondi ML, Battaglioli L, Zambon A, Guagnellini E, Scorza R. Genetic risk factor characterizes abdominal aortic aneurysm from arterial occlusive disease in human beings: CCR5 Delta 32 deletion. J Vasc Surg. 2004;40:995–1000.

    Article  PubMed  Google Scholar 

  27. Salvarani C, Boiardi L, Timms JM, Silvestri T, Ranzi A, Macchioni PL, et al. Absence of the association with CC chemokine receptor 5 polymorphism in polymyalgia rheumatica. Clin Exp Rheumatol. 2000;18:591–5.

    PubMed  CAS  Google Scholar 

  28. Zhou Y, Kurihara T, Ryseck RP, Yang Y, Ryan C, Loy J, et al. Impaired macrophage function and enhanced T cell-dependent immune response in mice lacking CCR5, the mouse homologue of the major HIV-1 coreceptor. J Immunol. 1998;160:4018–25.

    PubMed  CAS  Google Scholar 

  29. Ajuebor MN, Wondimu Z, Hogaboam CM, Le T, Proudfoot AE, Swain MG. CCR5 deficiency drives enhanced natural killer cell trafficking to and activation within the liver in murine T cell-mediated hepatitis. Am J Pathol. 2007;170:1975–88.

    Article  PubMed  CAS  Google Scholar 

  30. Takeuchi A, Usui Y, Takeuchi M, Hattori T, Kezuka T, et al. CCR5-deficient mice develop experimental autoimmune uveoretinitis in the context of a deviant effector response. Invest Ophthalmol Vis Sci. 2005;46:3753–60.

    Article  PubMed  Google Scholar 

  31. Ramshaw AL, Parums DV. Immunohistochemical characterization of inflammatory cells associated with advanced atherosclerosis. Histopathology. 1990;17:543–52.

    Article  PubMed  CAS  Google Scholar 

  32. Ramshaw AL, Roskell DE, Parums DV. Cytokine gene expression in aortic adventitial inflammation associated with advanced atherosclerosis (chronic periaortitis). J Clin Pathol. 1994;47:721–7.

    Article  PubMed  CAS  Google Scholar 

  33. Weyand CM, Hicok KC, Hunder GG, Goronzy JJ. Tissue cytokine patterns in patients with polymyalgia rheumatica and giant cell arteritis. Ann Intern Med. 1994;121:484–91.

    Article  PubMed  CAS  Google Scholar 

Download references

Conflict of interest

None.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Carlo Salvarani.

About this article

Cite this article

Pazzola, G., Boiardi, L., Casali, B. et al. CC chemokine receptor 5 polymorphism in Italian patients with giant cell arteritis. Mod Rheumatol 23, 851–855 (2013). https://doi.org/10.1007/s10165-012-0751-5

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10165-012-0751-5

Keywords

Navigation